Researchers demonstrate the potential of the low risk tobacco product to help reduce the impact of tobacco related...
19 Jun 2017 9:31 AM IST
Patients with non-small-cell lung cancer survived for 13.8 months on average on the drug called atezolizumab
13 Dec 2016 9:47 AM IST